Global Gigantism Drugs Market, By Drug Class (Growth Hormone Inhibitors, Dopamine Agonist, Others), Drug Type (Generic, Branded), End-Users (Hospitals, Specialty Clinics, Home Healthcare, Others), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028

The Antipsychotic Drugs Market growth at a CAGR of 8.5% & expected USD 25805.39 million by 2029. It is analyzed as indication, drug class, distribution channel and end-user.

Topical Non-Steroidal Anti-Inflammatory Drugs Market was USD 2,648.65 million in 2022 and will reach USD 3973.29 million, growing at a CAGR of 5.20% by 2030

The performance enhancing drugs market is anticipated to rise at a CAGR of 5.30% in the forecast period by 2029 & it is analyzed by type, products and end user.

Epilepsy Drugs Market is expected to reach US$ 7.92 billion in 2024 to US$ 11.85 billion by 2033, with a CAGR of 4.57% from 2025 to 2033

The Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market was USD 177,430.32 million in 2022, will be USD 325,986.34 million, growing at a 9.10% by 2030

The Angiofibroma Drugs Market boost up with a CAGR of 7% & projected USD 5.15 billion by 2030. It is divided into treatment, distribution channel and end-user.

Oral Nonsteroidal Anti-Inflammatory Drugs Market was valued at USD 20,697.05 million in 2022, and it would grow to USD 32,641.01 billion, growing at around 5.86% by 2030

Anti-Dermatomycosis Skin Drugs Market was USD 16,240.00 million in 2022, is predicted to reach USD 21,368.45 million, and will grow at a CAGR of 3.49% by 2030

The Pediatric Drugs Market growth at a CAGR of 12.5% & expected USD 300.70 billion by 2029. It is analyzed as drug type, route of administration, end-users and distribution channel.